Importantly, a study revealed the relation between SLC7A5 overexpression and tamoxifen resistance in breast cancer cells, and silencing SLC7A5 expression was sufficient to increase the sensitivity of cancer cells to tamoxifen. This evidence concerns the gene SLC7A5 and breast carcinoma.